Slate Path Capital reported a 7.5% stake in Tvardi Therapeutics TVRD · 704,118 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 7.5%
Last report: First report
Shares held: 704,118 sh
Class: Common stock, par value $0.001 per share
Stock: Tvardi Therapeutics TVRD
Holder: Slate Path Capital
Event date: 25/06/30
Filed: 25/08/14

First 5%+ report · 7.5% stake

Tvardi Therapeutics trades, last 26 weeks

What else happened in Tvardi Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Slate Path Capital's other 5% stake reports

Slate Path Capital
5% stakeWolfspeed
5% stake
Wolfspeed
WOLF
9.99% stake
6,438,156 sh
9.99% stake
Filed 05/15
Slate Path Capital
5% stakeRocket Companies
5% stake
Rocket Companies
RKT
2% stake
19,358,000 sh
2% stake
Filed 25/10/21